Stepwise logistic regression analysis showed that independent predictors of acute myocardial infarction in patients admitted within 4 hours after onset of chest pain were electrocardiographic changes and creatine kinase MB mass concentration on admission; in patients admitted 4-12 hours after the onset of pain independent predictors were electrocardiographic changes and creatine kinase MB mass concentration and activity. Conclusion-Creatine kinase MB mass concentration is a more sensitive marker for myocardial infarction than the activity of creatine kinase and its MB isoenzyme. Electrocardiographic changes on admission in combination with creatine kinase MB mass concentration (instead of creatine kinase and creatine kinase MB activities) are best in diagnosing myocardial infarction.
Abstract
Objective-To assess the diagnostic value at admission of creatine kinase MB mass concentration, alone or in combination with electrocardiographic changes, in suspected myocardial infarction. Design-Prospective study of all consecutive patients admitted within 12 hours after onset of chest pain to a coronary care unit for evaluation of suspected myocardial infarction. Setting-Large regional hospital. Patients-In 297 patients creatine kinase and creatine kinase MB activities and creatine kinase MB mass concentration were determined. Myocardial infarction according to the criteria of the World Health Organisation was diagnosed in 154 patients and excluded in 143 patients (including 70 with unstable angina pectoris). Results-Sensitivitylspecificity for creatine kinase MB mass concentration in patients admitted within 4 hours and 4-12 hours after onset of chest pain were 450/6194% and 760/o179% respectively. Corresponding values for creatine kinase activity were 200/1890/6 and 59%1lo83%, and for creatine kinase MB activity 161/o187% and 530%1l87%. Raised creatine kinase MB mass concentration was seen in 17% of patients with unstable angina pectoris.
Stepwise logistic regression analysis showed that independent predictors of acute myocardial infarction in patients admitted within 4 hours after onset of chest pain were electrocardiographic changes and creatine kinase MB mass concentration on admission; in patients admitted 4-12 hours after the onset of pain independent predictors were electrocardiographic changes and creatine kinase MB mass concentration and activity. Conclusion-Creatine kinase MB mass concentration is a more sensitive marker for myocardial infarction than the activity of creatine kinase and its MB isoenzyme. Electrocardiographic changes on admission in combination with creatine kinase MB mass concentration (instead of creatine kinase and creatine kinase MB activities) are best in diagnosing myocardial infarction.
(Br Heart _ 1994;72:112-118)
The diagnosis of acute myocardial infarction is generally based on a history of chest pain, specific electrocardiographic changes, and the typical rise and fall in the activity of cardiac enzymes. At hospital admission the diagnostic value of chest pain,' single electrocardiographic recordings,23 and single determinations of the activity of creatine kinase and its MB isoenzyme-9 is limited. Serial measurement of creatine kinase and creatine kinase MB activities, as a reflection of myocardial cell damage, however, plays the most important part in establishing the definitive as well as the early diagnosis of myocardial infarction,'0 because these enzymes are easily and rapidly measured with automated analysers. The immunological determination of the mass concentration of creatine kinase MB is a recent advance towards greater sensitivity and specificity.1'-'5 Creatine kinase MB mass concentration is often raised in the early phase of myocardial infarction."3 16 Therefore, measuring creatine kinase MB mass concentration might be advantageous as it can be measured rapidly'7 like creatine kinase and creatine kinase MB activity.
In this study we assessed the validity of the reference ranges for a sensitive assay for creatine kinase MB mass concentration and creatine kinase and creatine kinase MB activities. We then evaluated the diagnostic properties of creatine kinase MB mass concentration at admission and compared them with those of the currently used methods for measuring creatine kinase and creatine kinase MB activities and electrocardiographic changes on admission. Finally, we evaluated the predictive power of combining these electrocardiographic changes with each of these biochemical markers at the time of admission.
Patients and methods
The study population consisted of all consecutive patients admitted over nine months to the coronary care unit of the Medisch Centrum Leeuwarden, a large regional hospital, for evaluation of suspected myocardial infarction within 12 hours after the onset of chest pain.
Patients were not included when they had been resuscitated or received defibrillation. Standard 12 lead electrocardiograms obtained at admission, 24 hours after admission, and at discharge were used for establishing the final diagnosis. Blood samples for the determination of activities of creatine kinase, its MB Contribution of creatine kinase MB mass concentration at admission to early diagnosis of acute myocardial infarction isoenzyme, lactate dehydrogenase, aspartate aminotransferase,, and alanine aminotransferase and the mass concentration of creatine kinase MB were taken at admission, three times in a fixed time schedule for the first 24 hours, and once-daily until discharge. DIAGNOSTIC 
CRITERIA
Electrocardiographic findings on admission were classified as normal, ischaemic, or nonconclusive. Normal findings were defined according to the criteria of the New York Heart Association.'8 Electrocardiographic rcsults were classified as ischaemic if the ST segment was depressed by more than 1 mm 0-08 s after the J point or the ST segment was elevated by more than 1 mm (in at least two contiguous leads) and provided that QRS complexes were normal and there was right bundle branch block. All other findings in electrocardiograms on admission were classified as non-conclusive.
Patients were classed as having myocardial infarction, unstable angina pectoris, or other cardiac disease or as having no acute ischaemic heart disease. The final diagnosis was established by an independent cardiologist who did not know the initial creatine kinase MB mass concentration. The diagnosis of myocardial infarction was established if a patient had at least two of the three classic findings. The first was a clinical history of ischaemic chest discomfort of more than 30 minutes' duration. The second was the development of typical changes in at least two leads of the electrocardiogram. Q waves greater than 0-04 s or an R/S ratio greater than 1 in leads Vl and V2 was termed Q wave infarction; ST segment depression of more than 1 mm 0-08 s after the J point or ST segment elevation of more than 1 mm persisting for at least 24 hours was termed non-Q wave infarction. The third was a time dependent change in serum creatine kinase and creatine kinase MB activities, showing an initial rise (with a peak value of creatine kinase MB activity exceeding twice the upper limit of normal values) and subsequent fall.
Unstable angina pectoris was defined as typical anginal pain at rest in combination with reversible or persistent electrocardiographic changes but without a peak value in activity of creatine kinase MB that exceeded twice the upper limit of normal values.
Patients were classed as having no acute ischaemic heart disease when there was a definite alternative source of the chest pain or an atypical history with a negative result on stress electrocardiography, myocardial scintigraphy, or coronary angiography. . The sensitivity of this assay was reported to be 0-2 .ug/1.20 The measuring range covers concentrations from 0-2 to 300 pug!l. The upper limit of normal values in this assay was established in this study using serum samples from 77 male and 45 female apparently healthy blood donors. The upper limit of normal (97-5th percentile) was estimated at 50 pug/l according to the proposed guidelines of the International Federation of Clinical Chemistry.2' STATISTICAL ANALYSIS Sensitivity, specificity, positive and negative predictive values, relative risk, and likelihood ratios were calculated to determine the diagnostic properties of electrocardiographic findings and the biochemical markers. The likelihood ratio of a positive test is the probability of a positive test in the presence of disease divided by the probability of a positive test in the absence of disease.
Differences in baseline characteristics (age, sex, clinical history, and risk factors) between patients with and without myocardial infarction were determined by a X2 test or by Fisher's exact test for categorical variables and by Student's t test for continuous variables (a P value <0 05 was considered to be significant).
A stepwise logistic regression analysis (PROC LOGISTIC22) was performed to identify the variables that contributed significant independent information to distinguish patients with myocardial infarction from those without. At each step of the logistic regression analysis the variable that was most significantly associated with the presence of myocardial infarction was selected until no variables meeting the 0 05 significance level (x2 test) for entering the model were left. The probability of myocardial infarction in each patient given electrocardiographic information alone and in combination with the biochemical markers was calculated by using the coefficients obtained in the logistic regression analysis.
Results
Our study included 297 patients (148 of them admitted within 4 hours after the onset of anginal chest pain). Acute myocardial infarction was confirmed in 154 patients (75 Q wave); 50 of them (32%) received thrombolysis. In 143 patients acute myocardial within the normal range. Electrocardiographic findings on admission were ischaemic in one patient with pericarditis (the patient with raised values for the three markers), in one patient with arrhythmia, and in one patient with congestive heart failure. Electrocardiographic findings were non-conclusive in one patient with pericarditis and in three patients with arrhythmia.
DIAGNOSTIC PROPERTIES OF MARKERS FOR MYOCARDIAL DAMAGE
Because the release of markers after myocardial infarction depends on the time elapsed since the onset of necrosis and because thrombolysis is most effective when started within four hours after the onset of chest pain, we related the diagnostic properties of the markers to the time between the onset of chest pain and admission (table 2). Table 3 shows the frequency of normal and abnormal results at admission on electrocardiography and for the biochemical markers, together with the relative risk and likelihood ratios.
COMBINATION OF ELECTROCARDIOGRAPHIC FINDINGS WITH ONE BIOCHEMICAL MARKER IN IDENTIFYING MYOCARDIAL INFARCTION
To determine the effect of combining the diagnostic tests, the electrocardiographic results, activities of creatine kinase and creatine kinase MB activities, and creatine kinase MB mass concentration were entered into a model for stepwise logistic regression analysis. In the group admitted within 4 hours after onset of chest pain the independent predictors of myocardial infarction were electrocardiographic findings on admission and creatine kinase MB mass concentration (table 4) .
Creatine kinase MB mass concentration strongly enhanced discrimination between patients with and without myocardial infarction when electrocardiographic findings were normal or non-conclusive. Table 5 shows the probabilities of myocardial infarction given admission electrocardiographic findings alone and in combination with one of the biochemical markers (the respective probabilities were calculated in a logistic regression model considering the combination of electrocardiographic findings and each marker separately).
In the patients admitted between four and 12 hours after onset of chest pain the activity of creatine kinase MB was an independent predictor of myocardial infarction in addition to the electrocardiographic findings and creatine kinase MB mass concentration.
Discussion
Establishing the diagnostic value of tests requires proper validation of normal ranges, which are usually estimated in serum samples from healthy blood donors or laboratory staff; these subjects are young and healthy compared with the patients the test is meant for. We therefore verified the upper limit of normal values for the cardiac markers in patients who were admitted for evaluation of possible myocardial infarction, and classed as having no acute ischaemic heart disease at discharge from hospital. Falsely raised results for creatine kinase and creatine kinase MB activities were found as a result of known causes such as muscle injury,5 the occurrence of macromolecular creatine kinase,7-9 and the release of adenylate kinase from haemolysed erythrocytes. 56 Raised results in patients with no evidence of acute ischaemic heart disease were encountered to a far lesser extent for creatine kinase MB mass concentration. Although creatine kinase MB mass concentration may rise above the upper limit of normal values after heavy physical exercise,23 no evidence of muscular damage was found in the first patient with a raised creatine kinase MB mass concentration. In the other patient with a raised creatine kinase MB mass concentration, creatine kinase and creatine kinase MB activities were raised as a result of the presence of a macromolecular creatine kinase, so muscular damage could not be excluded with certainty. For creatine kinase MB mass concentration the upper limit of normal values found in our study was supported not only by the findings in the patients with no acute ischaemic heart disease but also by the 26 As a consequence, minor myocardial damage, which remained undetectable with the less sensitive assays for creatine kinase and creatine kinase MB activities used so far, is probably present in patients with unstable angina pectoris and a raised creatine kinase MB concentration. To adapt the upper limit of normal values for creatine kinase MB mass concentration on the basis of the results in patients with unstable angina pectoris is not therefore justified.
In patients presenting with acute chest pain shortly (<4 hours) after onset accurate early diagnosis is an important requirement to assure proper allocation of expensive coronary care beds, to identify patients with acute myocardial infarction who may benefit from interventions aimed at limiting the size of the infarct,3 2831 and to avoid premature discharge from hospital of patients with myocardial infarction. Selection of therapeutic measures is guided by clinical history, age of the patient, coagulation state, and the diagnostic facilities available to the physician. Objective biochemical data, although desirable, are not currently available for the decision making process because the currently used markers, creatine kinase and creatine kinase MB activities, have a low diagnostic sensitivity at admission (creatine kinase 20%, creatine kinase MB 16%). Creatine kinase MB mass concentration seems to have a significantly better diagnostic sensitivity (45%) shortly after onset of chest pain.121316 Moreover, this biochemical assay can be performed rapidly.'7 The electrocardiogram on admission is another objective measure for early detection of myocardial infarction. ST segment changes were found to be the most sensitive criterion.232-34 Specific ST changes may, however, be absent in the early phase of acute myocardial infarction in 40-60% of patients (in our study, 57%). Although electrocardiographic recordings can be performed easily and rapidly, the diagnostic accuracy shortly after onset of chest pain is limited.
To improve the diagnostic possibilities at admission shortly after onset of chest pain, we investigated the diagnostic power of combining the electrocardiographic findings on admission with creatine kinase MB mass concentration on admission. With this combination of tests, which both can be performed rapidly, the diagnostic accuracy increases considerably in comparison with electrocardiographic findings, alone or in combination with creatine kinase or creatine kinase MB activity. In patients admitted between four and 12 hours after the onset of chest pain the results are less convincing for creatine kinase MB mass concentration as a consequence of the high false positive rate in patients with unstable angina pectoris. The higher sensitivity of creatine kinase MB mass concentration for myocardial cell necrosis is accompanied by a lower specificity because patients with minor myocardial damage and a raised creatine kinase MB mass concentration will be called false positive according to the WHO criteria. Such a classification, however, does not account for the significance of detecting minor myocardial cell damage in patients not yet fulfilling the WHO criteria for diagnosis of myocardial infarction. These patients carry an increased risk of dying or having a major myocardial infarction,2627 and they may be detected by measuring creatine kinase MB mass concentration. Thereby these patients constitute a subgroup, which might benefit from a more aggressive treatmentthat is, coronary angiography followed by subsequent revascularisation.
Usually, the presence of specific ST changes has such a high positive predictive value for the diagnosis of myocardial infarction2 34 that little further information is needed when this electrocardiographic finding is present, especially in conjunction with appropriate symptoms. Unfortunately, many patients with myocardial infarction will have other findings on an admission electrocardiogram.
Many patients presenting with suggestive symptoms and without characteristic findings on an admission electrocardiogram will have unstable angina or non-cardiac diagnoses, while others will have myocardial infarction. Our results show that creatine kinase MB mass concentration constitutes a major improvement in the diagnostic process. Further improvement probably can be obtained by using creatine kinase MB subforms,35 but such measurements are not yet practicable because labour and time consuming electrophoretic methods are needed. In patients with non-conclusive electrocardiographic findings-that is, patients with a left bundle branch block-and clinical suspicion of myocardial infarction creatine kinase MB mass concentration might be helpful in deciding whether thrombolysis is needed.
In conclusion, we have four main findings.
(1) Creatine kinase MB mass concentration is more sensitive in detecting patients with acute myocardial infarction than creatine kinase and creatine kinase MB activities.
(2) Creatine kinase MB mass concentration in combination with electrocardiographic findings on admission best distinguishes patients with myocardial infarction from those without when admission is within 4 hours after the onset of chest pain.
(3) In patients with a final diagnosis of no acute ischaemic heart disease considerably less false positive results were encountered using creatine kinase MB mass concentration instead of creatine kinase and creatine kinase MB activities.
(4) In patients with unstable angina pectons creatine kinase MB mass concentration was raised in a considerable number of patients in contrast with creatine kinase and creatine kinase MB activities, thereby allowing detection of a subgroup of patients with possibly an increased risk for major cardiac events.
We conclude that for early diagnosis of myocardial infarction rapid assays for the determination of creatine kinase MB mass concentration should replace the measurements of creatine kinase and creatine kinase MB activities.
The reagents for the immunological determination of creatine kinase MB mass concentration were given by Abbott.
